These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29303868)

  • 1. Substance Abuse Surveillance Among Construction Workers: A Proof of Concept Alternative Approach.
    Caban-Martinez AJ; Sierra D; Ruano-Herreria EC; Reidy LJ
    J Occup Environ Med; 2018 Mar; 60(3):e157-e158. PubMed ID: 29303868
    [No Abstract]   [Full Text] [Related]  

  • 2. Substance use in the construction industry: a comparison of assessment methods.
    Hersch RK; McPherson TL; Cook RF
    Subst Use Misuse; 2002 Sep; 37(11):1331-58. PubMed ID: 12371575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Practical guide" to urine drug screening clarified.
    Reisfield GM; Bertholf RL
    Mayo Clin Proc; 2008 Jul; 83(7):848-9; author reply 849. PubMed ID: 18614000
    [No Abstract]   [Full Text] [Related]  

  • 4. Urine adulterant test for oxidants yields positive results from microbial-contaminated urine.
    Brazwell E; Crossey M; Racz M; Quitoriano T; Chavez M
    J Anal Toxicol; 2004; 28(8):692-3. PubMed ID: 15586447
    [No Abstract]   [Full Text] [Related]  

  • 5. Objective Testing: Urine and Other Drug Tests.
    Hadland SE; Levy S
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):549-65. PubMed ID: 27338974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic investigations of novel validity parameters in urine drug testing and prevalence of urine adulteration in a two-year cohort.
    Kluge J; Rentzsch L; Remane D; Peters FT; Wissenbach DK
    Drug Test Anal; 2018 Oct; 10(10):1536-1542. PubMed ID: 29956490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid assessment methodology: its origins, development and use by the United Nations International Drug Control Programme.
    Bull Narc; 1996; 48(1-2):1-10. PubMed ID: 9839032
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of substance abuse monitoring in a social services context: a primer for child protection workers.
    Moller M; Gareri J; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e177-93. PubMed ID: 20436210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilution of Urine Followed by Adulteration in an Attempt to Deceive the Laboratory.
    Feldhammer M; Saitman A; Nguyen L; Milstid B
    J Anal Toxicol; 2019 Jan; 43(1):e7-e9. PubMed ID: 30192938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of thin-layer chromatography methods for laxative detection.
    Duncan A; Phillips IJ
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):64-6. PubMed ID: 11270846
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder.
    Arvidsson M; Ullah S; Franck J; Dahl ML; Beck O
    Drug Test Anal; 2019 Jan; 11(1):27-32. PubMed ID: 29575801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug screens.
    Collen M
    J Pain Palliat Care Pharmacother; 2011; 25(4):395. PubMed ID: 21929326
    [No Abstract]   [Full Text] [Related]  

  • 13. Surveillance of emerging drugs of abuse in Hong Kong: validation of an analytical tool.
    Tang M; Ching CK; Tse ML; Ng C; Lee C; Chong YK; Wong W; Mak TW;
    Hong Kong Med J; 2015 Apr; 21(2):114-23. PubMed ID: 25756277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative urine screening for the diagnosis and treatment of cocaine abuse.
    Tennant F
    NIDA Res Monogr; 1989; 95():318-9. PubMed ID: 2701298
    [No Abstract]   [Full Text] [Related]  

  • 16. Substance use by liver transplant candidates: an anonymous urinalysis study.
    Webzell I; Ball D; Bell J; Sherwood RA; Marsh A; O'Grady JG; Heaton ND
    Liver Transpl; 2011 Oct; 17(10):1200-4. PubMed ID: 21744466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of quantitative urinalysis in monitoring cocaine use.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    NIDA Res Monogr; 1997; 175():253-64. PubMed ID: 9467803
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric fluid analysis for determining gestational cocaine exposure.
    Garcia DC; Romero A; Garcia GC; Ostrea EM
    Pediatrics; 1996 Aug; 98(2 Pt 1):291-3. PubMed ID: 8692634
    [No Abstract]   [Full Text] [Related]  

  • 20. Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications.
    Kirsh KL; Christo PJ; Heit H; Steffel K; Passik SD
    J Opioid Manag; 2015; 11(1):53-9. PubMed ID: 25750165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.